Comparative study of intraoperative application of daunorubicin and conjunctival autograft in primary pterygium surgery: an interesting followup study

Abha Sinha, Vireshwar Prasad


Background: The exact aetiology and pathogenesis of pterygium remains unclear but it is more common in people with excessive outdoor exposure to sunlight and wind, such as those who work outdoors. Pterygium is of great concerns to both surgeons and patients, as it has been shown to recur in up to 97% of patients within one year after surgical removal. Different adjuvant procedures like lamellar corneal graft, irradiation etc. to prevent recurrence is not encouraging. Of late a new anticancer drug named Daunorubicine (0.02%) has been used intraoperatively in pterygium surgery by one of the study with promising results. Pterygium excision with Conjunctival Autografting is very popular technique to prevent recurrence with very few side effects. This is being tried out with success in different country.

Methods: The study was carried out on 60 patients who presented to the eye department at Darbhanga medical college and hospital, Laheriasarai (Bihar), India during the period from May 2005 to may 2006, & was analysed retrospectively. Efforts were made to select patients with primary fleshy pterygium.

Patients selected were divided into two groups group 1 & group 2. All patients under this study were suggested to a thorough general & ocular examination. Pterygium excision in all selected cases was done under topical 4% lignocaine drop & subconjunctival injection of 2% lignocaine with adrenaline; pterygium was slowly dissected out. After the pterygium was removed from over the cornea subconjunctival dissection of the fleshy mass was done. The graft, over the scleral bed, was smoothed & spread out; the suture is done with 10-0 nylon. Post – operative management was done. The subsequent checkups were on 15th post-operative day, at 1st month, 3rd month & 6th month & same procedures were followed up to 1 year. Data was compiled in MS-Excel and checked for its completeness and correctness. Then it was analyzed.

Results: Majority of patients was of age group ranged from 31 years to 50 years. 11 patients were less than 30 years of age. In group I, out of 30 eyes of 30 patients three eyes (10 %) had bilateral pterygium (both nasal and temporal). Two eyes (6.7%) had temporal pterygium. Rest 25 eyes (83.3%) had pterygium located nasally. In group II, out of 30 eyes of 30 patients two eyes (6.7%) had bilateral pterygium. Three eyes (10%) had temporal pterygium. Rest twenty five eyes (83.3%) had pterygium located nasally. Improvement of visual acuity in most of the patient after pterygium surgery. In group I, out of 30 eyes, two patients had developed recurrence, so the recurrence rate in group I is 6.6 %. In group II, out of 30 eyes, one patient had developed recurrence. So the recurrence rate in group II is 3.3%.

Conclusions: The present study concluded that both the procedures are equally effective adjuncts to prevent recurrence in pterygium surgery.



Pterygium, Conjunctival autograft, Daunorubicin.

Full Text:



Parsons diseases of the eye, Elsevier publication, 19th edn, 193.

Hirst LW, Sebban A, Chant D, Pterygium recurrence time, Ophthalmology 1994,101:755-8.

Adamis AP, Starck T, Kenyon KR. The management of pterygium. Ophthalmol Clin North Am. 1990;3:611–23.

Tan Donald TH, Chee S-P, Dear Keith BG, et al. Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival auto grafting with bare sclera excision. Arch Ophthalmol. 1997; 115:1235–40.

Desmarres LA. TraiteTheoriqueetPratique des Maladies des Yeu, 2nd ed. Paris: G. Baillere; 1855:128.

Knapp H. A new plastic conjunctival operation. Arch Ophthalmol.1868;14:270–2.

McReynolds JO. The nature and treatment of pterygia. JAMA. 1902;39: 296–299.

D’Ombrain A The surgical treatment of pterygium. Br. J. Ophthal 1948;32:65-71.

Kunitomon et al. Studies on the pterygium,a treatment of the pterygium by mitomycin-C instillation. Nippon GankkaiZasshi. 1963:67:601.

Cano-Parra J, Diaz-Llopis M, Maldonado MJ, Vila E, Menezo JL. Prospective trial .of intraoperative mitomycin C in the treatment of primary pterygium, British Journal of Ophthalmology. 1995;79:439-41.

Pada A, Das GK, Tuli S.W., Kumar AR. Randomized trial of intraoperative mitomycinC in surgeryforpterygium. Amj Ophthal. 1998:125(1):59-63.

Parthasarathy NR, Gupta UC. Prevalence of pterygium in rural India. orient Arch Ophthal. 1967;5:139-147.

Gerundo. The etilogy and pathology of pterygium, American journal Of Ophthalmology. 1951;34,851-6.

Kenyon KR, Wasoneu MD, Hethinger ME. Conjunctivalautograft transplantation for advanced and recurrent Pterygium. Ophthalmology. 1985;92:1461-70.

Simona F, Tabatabay CA, Leunberger PM. Preliminary results of the pterygium excision technique with conjunctival autograft. 1990;196(5):295-7.

Allan BDS, Short P. Pterygium excision with conjunctival grafting: an effective and safe technique. Br J Opthalmol. 1993;77:698-701.

Kotch JM, Mellin KB, Waubke TN. Thepterygium autologous conjunctiva- limbus transplantation as treatment. Ophthalmology. 1992:89:143-6.

Güler M, Sobaci G, Ilker S, Oztürk F, Mutlu FM, Yildirim E. Limbal-conjunctivalautograft transplantation in cases with recurrent pterygium. ActaOphthalmol (Copenh). 1994;72:721–6.

Figueiredo RS, Cohen EJ, Gomes JAP, Rapuano CJ, Laibson PR. Conjunctival autograft for pterygiumsurgery. How well does it prevent recurrences. Ophthalmic Surgery Lasers. 1997;28:99.

Dadeya et al. Intraoperative daunorubicin to prevent the recurrence of pterygium after excision. Cornea. 2001;20(2):172-4.

Dadeya et al. Intraoperative daunorubicin versus conjunctivalautograft in primary pterygium surgery Cornea. 2002;21(8):766-9.